Virus- and oncogene-free reprogramming method for the production of iPSCs published in the journal Regenerative Medicine

(Future Science Group) Regenerative Medicine is delighted to publish open access original research demonstrating the first virus- and oncogene-free induced pluripotent stem cell (iPSC) technology to produce safer pluripotent stem cells from cord blood and peripheral blood.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news